CNS Pharmaceuticals, Inc.
CNSP
|
NASDAQ
|
0 Followers
Company Quality
Profitability Score
3/100
Solvency Score
50/100
Dividends
Dividends data currently unavailable.Earnings
8/12/2025
in 58 days
-
Revenue est.
-
EPS est.
My Notes
You haven't added any notes for this stock yet. Use this space to record your insights or strategies.
Profile
Healthcare
Sector
Biotechnology
Industry
Mr. John Michael Climaco Esq., J.D.
CEO
4
Employees
Houston
Headquarters
US
Country
Key Metrics TTM
Valuation
Market cap.
$4.4MEnterprise Value
-$8.4MPrice to Earnings
-0.14Price to Sales
1,404Price to Book
0.20Price to Cash Flow
-0.26Profitability
Return on Assets
-113.57%Return on Equity
-385.41%Return on Invested Capital
-140.37%Gross Margin
2.13%Operating Margin
-499,833.00%Net Margin
-497,273.00%Liquidity
Quick Ratio
4.94Current Ratio
4.94Cash Ratio
4.69Inventory Turnover
0.00Asset Turnover
0.0002Total Liabilities
$2.8MSolvency
Debt to Assets
0.02Debt to Equity
N/AInterest Coverage
-4,775Equity Ratio
0.80Long-term Debt to Cap.
0.00Altman Z-Score
-10.60Performance
Earnings Waterfall
Debt level and coverage
Earnings
Feed
There are no posts to show right now.